Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
He encourages them to schedule an in-person or video visit if they need help
Ro Offers Eli Lilly's Foundayo, the Newest GLP-1 Innovation Foundayo gives patients a new once daily pill option and expands Ros comprehensive weight loss formulary April 9, 2026 Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Companys newest oral GLP-1 innovation on the Ro platform, adding to Ros already comprehensive formulary of FDA-approved GLP-1s
All information presented is based on published clinical trial data and is not intended to encourage off-label use
Our AI advisor helps you determine if you're a candidate for aggressive protocols or if safer alternatives are better suited
US$ 24.83
US$ 21.21
US$ 20.30
US$ 22.78
US$ 23.27
US$ 26.38
US$ 25.47
US$ 29.76
US$ 22.20
US$ 25.85
